Therapeutic use of activators of zinc finger protein GL13
US9540648B2 · kind B2 · utility
0Cited by
9References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 25, 2013 |
| Grant date | Jan 10, 2017 |
| Priority date | — |
| Expiry date | Jan 25, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the therapeutic use of activators of the zinc finger protein GLI3 in diseases that are associated with reduced Hedgehog signaling in hepatocytes, in particular Polycystic ovary syndrome, Steatosis hepatis, Steatohepatitis and/or Adipositas. The invention further relates to methods of treating an individual with said activator, a pharmaceutical composition comprising said activator and the use of said activator as food supplement.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.